Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.

Cytometry. Part B, Clinical cytometry - 1 Jan 2000

Della Porta Matteo Giovanni, Lanza Francesco, Del Vecchio Luigi

Abstract excerpt

The pathological hallmark of myelodysplastic syndromes (MDS) is marrow dysplasia, which represents the basis of the WHO classification of these disorders. This classification provides clinicians with a useful tool for defining the different subtypes of MDS and determining individual prognosis. The WHO proposal has raised some concern regarding minimal diagnostic criteria particularly in patients with normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Bone Marrow
Share to Erythroid Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Immunophenotyping

Share to Myelodysplastic Syndromes

Share to Phenotype

Share to World Health Organization

Source

Identifiers

PMID: 21674774
DOI: 10.1002/cyto.b.20607

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.PMID 21674774Read ↗

The Use of Flow Cytometry in Myelodysplastic Syndromes: A ReviewSemantic proximity Read ↗

Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?Semantic proximity Read ↗

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.Semantic proximity Read ↗

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromesSemantic proximity Read ↗

Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.Semantic proximity Read ↗

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesSemantic proximity Read ↗

The role of flow cytometry in myelodysplastic syndromes.Semantic proximity Read ↗

Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile.Semantic proximity Read ↗

Flow cytometry in hematological nonmalignant disorders.Semantic proximity Read ↗

Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.Semantic proximity Read ↗

Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common.Semantic proximity Read ↗

Diagnosis of Myelodysplastic Syndrome Among a Cohort of 119 Patients With Fanconi AnemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.